Skip to main content
. Author manuscript; available in PMC: 2022 Sep 6.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):217–226. doi: 10.1016/j.ijrobp.2020.05.062

Figure 2:

Figure 2:

Overall survival of patients with adrenal metastases treated with SBRT based on one-year estimates; α/β=10 Gy in this model. The figure shows OS estimates at 50%, 80%, 90%, and 95% (blue dotted horizontal lines). The black dashed curves show the 95% confidence band and the GTV coverage dose scales are for EQD210, BED10, and equivalent doses in 3 and 5 fractions.